A pharmaceutical composition that blocks angiogenesis comprising as active agent at least one substance selected from the group consisting of (i) a nucleic acid molecule of a gene coding for protein IRS-1, a complementary sequence or a fragment thereof and (ii) a molecule which inhibits expression of a nucleic acid molecule according to (i).

 
Web www.patentalert.com

< Biologically active conjugate of a biopolymer and therapeutic agent

> Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
~ 00456